Alterations for acid and alkaline phosphatase levels and their pattern of splenic and lymph node activity in normal and virus-induced lymphoblastic leukemia were studied. Enzyme levels were examined by using both cytochemical and biochemical procedures. The GC leukemia virus, a ribonucleic acid murine virus antigenically related to the Rauscher-Moloney viruses, was used to stimulate acid and alkaline phosphatase by producing lymphomaceous disease in Ha/ICR mice. With the Burstone and Gomori cytochemical procedures, both enzymes were found in higher than normal levels in lymphomaceous spleen and lymph nodes. Confirmation of the cytochemical studies was obtained by enzyme assay of cell-free homogenates in each case with the exception of spleen acid phosphatase. The discrepancy between the cytochemical tests which showed significant elevation of spleen acid phosphatase and the enzyme assays which failed to reveal such elevation could be due to a labile acid phosphatase isozyme which is lost on cellular disruption during homogenate preparation. A significant spleen alkaline phosphatase specific activity elevation above normal was found with a 50% incidence only when leukemic spleen wet weight increased nearly threefold its normal value. This result suggests that alkaline phosphatase elevation is a secondary event occuring after the onset of disease and is not a fundamental metabolic alteration concerned with the onset of murine lymphoblastic leukemia.
Several studies have demonstrated elevation of alkaline phosphatase in leukemic mouse reticuloendothelial organs (7, 11, (14) (15) (16) (19) (20) (21) . Also, higher amounts of acid phosphatase have been detected in peripheral blood cells following Rauscher leukemia virus infection (12) . Such studies on enzymes and their alterations in malignant cells should lead to a better understanding of neoplasia, a prerequisite for successful therapy. Accordingly, in the present investigation, alterations of both acid and alkaline phosphatase levels and their pattern of activity in spleen and lymph node cells of mice with a viralinduced lymphoblastic leukemia have been examined. Both cytochemical and biochemical procedures were employed. The lymphoma virus used, designated GC (10) , is of the ribonucleic acid (RNA) type (2) and antigenically related to the Friend-Moloney-Rauscher group (3).
MATERIALS AND METHODS
Animals. Two to 4-day-old random-bred Ha/ICR Swiss mice were inoculated intraperitoneally with GC virus as previously described (10 Gomori (9) , its modification as recommended by Pearse (17) , and Burstone's azo-dye staining (4) were used to study alkaline phosphatase. Prior to treatment by Gomori's method, impression smears were frozen in powdered dry ice for 5 min. After fixation in cold (4 C) (Table 2) ; however, only in leukemic animals when spleen wet weight was frankly increased above normal did the level of alkaline phosphatase rise substantially.
A total of 37 spleens from leukemic animals (average wet weight, 915 mg; range, 280 to 1,750 mg) and 13 from normal animals (average wet weight, 200 mg; range, 120 to 340 mg) were tested individually for alkaline phosphatase specific activity. These results (Fig. 4) 5 hr of incubation at 37 C. Spleens from the same animals described in Fig. 2 b Two lymphomaceous spleen homogenates with nearly the same level of phosphatases were tested, and the results were averaged (spleen wet weights, 800 and 1,050 mg). Two normal spleen cell-free homogenates were examined, and the results were also averaged (spleen wet weights, 180 and 140 mg). Two lymphomaceous and two normal lymph node preparations were used, and the results were averaged in each case. The leukemic node preparations were from individual animals (node wet weights, 1,500 and 820 mg), whereas each normal node preparation was pooled material from three mice (pooled node wet weights, 100 and 90 mg). a Infected Ha/ICR mice were inoculated at 2 days of age with GC lymphoma virus. A spleen impression smear of each infected animal tested was also examined for leukemia after Giemsa staining. From 9 to!40 days of age, no leukemia was evident. The 48-, 60-, and 74-day-old animals each had some degree of lymphoblastic leukemia.
b Cell-free homogenates were assayed in tris(hydroxymethyl)aminomethane-hydrochloride buffer (pH 9.1) for alkaline phosphatase and in sodium acetate buffer (pH 5.0) for acid phosphatase. One unit of activity signifies the release of 1 zyme assay) between spleens from normal and inoculated animals sacrificed during the latency period ( (6, 19) . In this study, longer incubation periods resulted in the additional appearance of positively staining granules scattered throughout the cytoplasm which were always more evident in lymphomaceous material. Cytochemical observations demonstrating elevation of alkaline phosphatase have been reported for thymus of both AKR and C57BL mice infected with other murine leukemia viruses (11, 15, 20, 21 (14) . The data reported here, which show alkaline phosphatase specific activity elevation in lymphomaceous spleen is not the result of animal age or sex or due to differences between normal and leukemic spleen protein levels, support this view.
To our knowledge there has been only a single report on the elevation of acid phosphatase in viral-induced murine leukemia (12) . In this instance, cytochemical studies demonstrated elevated acid phosphatase in erythroblastic murine leukemia following Friend virus inoculation. The cytochemical observations reported here by using two different methods (Gomori and Burstone) demonstrate consistent elevation of acid phosphatase in both spleen and lymph nodes following the onset of GC virus-induced lymphoblastic leukemia. Confirmation of these cytochemical observations by enzyme assays was obtained with lymph node homogenates by using PNPP as well as the same substrates employed for cytochemical analysis. With spleen homogenates, however, biochemical tests failed to demonstrate the acid phosphatase elevation detected cytochemically. This could be due to the presence of a labile acid phosphatase isozyme which is lost upon preparation of lymphomaceous spleen homogenates.
